PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation

Summary: Vascular aging is an independent risk factor for cardiovascular diseases, but the regulatory mechanism is not clearly understood. In this study, we found that endothelial PKR activity is elevated in aging aorta tissues, which is accompanied with increased endothelial cell hyperactivation, I...

Full description

Bibliographic Details
Main Authors: Zhouyangfan Peng, Xiqing Tan, Liangpeng Xie, Ze Li, Sufang Zhou, Yapei Li
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222021824
_version_ 1797946148479041536
author Zhouyangfan Peng
Xiqing Tan
Liangpeng Xie
Ze Li
Sufang Zhou
Yapei Li
author_facet Zhouyangfan Peng
Xiqing Tan
Liangpeng Xie
Ze Li
Sufang Zhou
Yapei Li
author_sort Zhouyangfan Peng
collection DOAJ
description Summary: Vascular aging is an independent risk factor for cardiovascular diseases, but the regulatory mechanism is not clearly understood. In this study, we found that endothelial PKR activity is elevated in aging aorta tissues, which is accompanied with increased endothelial cell hyperactivation, IL-1β and HMGB1 release and vascular smooth muscle cell (VSMC) phenotype transforming. Global knockout of PKR exhibits significantly delayed vascular aging compared to wild-type mice at the same age. In vitro, using PKR siRNA or the cell hyperactivation inhibitor glycine or disulfiram can effectively inhibit H2O2 or palmitic acid-induced endothelial cell hyperactivation, IL-1β and HMGB1 release and co-cultured VSMC phenotype transforming. These results demonstrate that endothelial PKR activation induces GSDMD-mediated endothelial cell hyperactivation to release HMGB1 and IL-1β, which promotes the phenotype transforming of VSMC and subsequent accelerates the process of vascular aging. These discoveries will help to explore the new drug target to inhibit vascular aging.
first_indexed 2024-04-10T21:06:22Z
format Article
id doaj.art-4eed84dc0e7b4b83880d492b0a9b0711
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-10T21:06:22Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-4eed84dc0e7b4b83880d492b0a9b07112023-01-22T04:41:50ZengElsevieriScience2589-00422023-01-01261105909PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivationZhouyangfan Peng0Xiqing Tan1Liangpeng Xie2Ze Li3Sufang Zhou4Yapei Li5Department of Health Management Center, the Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of General Practice, the Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Hematology and Critical Care Medicine, the Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Hematology and Critical Care Medicine, the Third Xiangya Hospital, Central South University, Changsha, ChinaSchool of Basic Medical Sciences, Guangxi Medical University, Nanning, ChinaDepartment of Health Management Center, the Third Xiangya Hospital, Central South University, Changsha, China; Corresponding authorSummary: Vascular aging is an independent risk factor for cardiovascular diseases, but the regulatory mechanism is not clearly understood. In this study, we found that endothelial PKR activity is elevated in aging aorta tissues, which is accompanied with increased endothelial cell hyperactivation, IL-1β and HMGB1 release and vascular smooth muscle cell (VSMC) phenotype transforming. Global knockout of PKR exhibits significantly delayed vascular aging compared to wild-type mice at the same age. In vitro, using PKR siRNA or the cell hyperactivation inhibitor glycine or disulfiram can effectively inhibit H2O2 or palmitic acid-induced endothelial cell hyperactivation, IL-1β and HMGB1 release and co-cultured VSMC phenotype transforming. These results demonstrate that endothelial PKR activation induces GSDMD-mediated endothelial cell hyperactivation to release HMGB1 and IL-1β, which promotes the phenotype transforming of VSMC and subsequent accelerates the process of vascular aging. These discoveries will help to explore the new drug target to inhibit vascular aging.http://www.sciencedirect.com/science/article/pii/S2589004222021824Biological sciencesPhysiologyCellular physiologyCell biology
spellingShingle Zhouyangfan Peng
Xiqing Tan
Liangpeng Xie
Ze Li
Sufang Zhou
Yapei Li
PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
iScience
Biological sciences
Physiology
Cellular physiology
Cell biology
title PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
title_full PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
title_fullStr PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
title_full_unstemmed PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
title_short PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation
title_sort pkr deficiency delays vascular aging via inhibiting gsdmd mediated endothelial cell hyperactivation
topic Biological sciences
Physiology
Cellular physiology
Cell biology
url http://www.sciencedirect.com/science/article/pii/S2589004222021824
work_keys_str_mv AT zhouyangfanpeng pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation
AT xiqingtan pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation
AT liangpengxie pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation
AT zeli pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation
AT sufangzhou pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation
AT yapeili pkrdeficiencydelaysvascularagingviainhibitinggsdmdmediatedendothelialcellhyperactivation